Trademark: 88925246
Status Date
Monday, December 25, 2023
Filing Date
Wednesday, May 20, 2020
Published for Opposition
Tuesday, September 29, 2020
Abandoned Date
Monday, December 25, 2023
5 Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Dec 26, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 25, 2023
Abandonment - No Use Statement Filed
Apr 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2023
Sou Extension 5 Granted
Apr 4, 2023
Sou Extension 5 Filed
Apr 12, 2023
Case Assigned To Intent To Use Paralegal
Apr 4, 2023
Sou Teas Extension Received
Oct 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 30, 2022
Sou Extension 4 Granted
Sep 30, 2022
Sou Extension 4 Filed
Sep 30, 2022
Sou Teas Extension Received
Apr 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 31, 2022
Sou Extension 3 Granted
Mar 31, 2022
Sou Extension 3 Filed
Mar 31, 2022
Sou Teas Extension Received
Oct 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2021
Sou Extension 2 Granted
Oct 27, 2021
Sou Extension 2 Filed
Oct 27, 2021
Sou Teas Extension Received
Apr 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2021
Sou Extension 1 Granted
Apr 5, 2021
Sou Extension 1 Filed
Apr 5, 2021
Sou Teas Extension Received
Nov 24, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 29, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 29, 2020
Published For Opposition
Sep 9, 2020
Notification Of Notice Of Publication E-Mailed
Aug 21, 2020
Approved For Pub - Principal Register
Aug 19, 2020
Assigned To Examiner
Jun 5, 2020
New Application Office Supplied Data Entered
May 23, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24